SA’s biggest pharmaceutical manufacturer, Aspen Pharmacare, is to receive a €600m (R10.1bn) long-term debt financing package from a consortium of development financiers led by the World Bank’s International Finance Corporation (IFC) to support the development of vaccine manufacturing capacity in Africa.

It is the first financing deal announced by the partnership, which was launched during French President Emanuel Macron’s visit to SA in May...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now